Your search returned 59 studies. (Get alerts for new studies):
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Fresno, California
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Fresno, California
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Visalia, California
- Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Conditions: Diabetic Type 1 With Obstructive Pulmonary Disease - Diabetic Type 2 With Obstructive Pulmonary Disease - Asthma - COPD - Diabetes Mellitus, Insulin-Dependent - Diabetes Mellitus, Non-Insulin-Dependent - Indeterminate Obstructive Lung Disease
Location: Fresno, California
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Conditions: Venous Thrombosis
Location: Fresno, California
- CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Fresno, California
- Black Widow Spider Antivenin for Patients With Systemic Latrodectism
Conditions: Latrodectism
Location: Fresno, California
- Efficacy of Methotrexate in Myasthenia Gravis
Conditions: Myasthenia Gravis
Location: Fresno, California
- Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Fresno, California
- Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine
Conditions: Meningococcal Meningitis
Location: Fresno, California
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Fresno, California
- Ventavis® Registry Protocol
Conditions: Pulmonary Arterial Hypertension
Location: Fresno, California
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Fresno, California
- Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Conditions: Osteoarthritis
Location: Fresno, California
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
Conditions: Partial Epilepsy
Location: Fresno, California
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease
Conditions: Chronic Kidney Disease
Location: Fresno, California
- Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Conditions: Epilepsy
Location: Fresno, California
- A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (
Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Location: Visalia, California
- Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia
Conditions: Chlamydia - Screening
Location: Fresno, California
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Fresno, California
- Flail Chest - Rib Fixation Study
Conditions: Flail Chest
Location: Fresno, California
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Fresno, California
- A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
Conditions: Venous Leg Ulcers
Location: Fresno, California
- An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
Conditions: Parkinson Disease - Idiopathic Parkinson Disease
Location: Fresno, California
- Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037 AM3)
Conditions: Parkinson Disease - Idiopathic Parkinson Disease - Idiopathic Parkinson's Disease
Location: Fresno, California
- Colonoscopy Versus Fecal Immunochemical Testing in Reducing Mortality From Colorectal Cancer (CONFIRM)
Conditions: Colorectal Cancer
Location: Fresno, California
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Fresno, California
- Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
Location: Fresno, California
- Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
Conditions: Myasthenia Gravis
Location: Fresno, California
- Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Conditions: Post Herpetic Neuralgia
Location: Fresno, California
- Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abn
Conditions: Primary Hypercholesterolemia - Mixed Dyslipidemia
Location: Fresno, California
- Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Conditions: Fibromyalgia - Painful Diabetic Peripheral Neuropathy
Location: Tulare, California
- DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
Conditions: Cervical Dystonia
Location: Fresno, California
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Visalia, California
- Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta Blockers
Conditions: Cardiac Event Risk
Location: Fresno, California
- Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
Conditions: Glaucoma
Location: Visalia, California
- Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients
Conditions: Infection Prophylaxis
Location: Fresno, California
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Location: Fresno, California
- Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regim
Conditions: Moderate to Severe Plaque-type Psoriasis
Location: Fresno, California
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Fresno, California
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Fresno, California
- Two Methods of Diagnosing Preterm Labor
Conditions: Preterm Labor - Preterm Delivery
Location: Fresno, California
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Fresno, California
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Fresno, California
- Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain
Conditions: Osteoarthritis - Low Back Pain
Location: Fresno, California
- Study of Tomography of Nephrolithiasis Evaluation
Conditions: Urolithiasis
Location: Fresno, California
- Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Conditions: Painful Diabetic Peripheral Neuropathy
Location: Fresno, California
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Bet
Conditions: Vaccines - Meningococcal Vaccines
Location: Fresno, California
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Fresno, California
- Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Conditions: Diabetic Peripheral Neuropathy
Location: Fresno, California
- Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis
Conditions: Meningococcal Meningitis - Meningococcal Infections
Location: Hanford, California
- Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-04
Conditions: Diabetes Mellitus - Type 2 Diabetes
Location: Fresno, California
- A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170)
Conditions: Diabetes Mellitus, Type 2
Location: Fresno, California
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Fresno, California
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Fresno, California
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Fresno, California
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: Fresno, California
- A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain
Conditions: Diabetic Neuropathic Pain
Location: Fresno, California
- Anterior Shoulder Dislocation
Conditions: Shoulder Dislocation
Location: Fresno, California
|